Literature DB >> 1985115

Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.

M E Rosenfeld1, J C Khoo, E Miller, S Parthasarathy, W Palinski, J L Witztum.   

Abstract

Pure macrophage-derived foam cells (MFC) were isolated from the aortas of rabbits made atherosclerotic by balloon deendothelialization followed by diet-induced hypercholesterolemia. The MFC were isolated under sterile conditions using an enzymatic digestion procedure and discontinuous density gradient centrifugation. The purity of the MFC preparations was verified immunocytochemically with the macrophage specific monoclonal antibody RAM-11. MFC plated in medium containing 0.5% FCS for 24 h contained approximately 600 micrograms cholesterol per mg cell protein, 80% of which was esterified cholesterol. The MFC specifically degraded low density lipoprotein (LDL), acetyl-LDL, copper oxidized LDL, and beta-very low density lipoprotein (beta-VLDL) at rates comparable to mouse peritoneal macrophages (MPM) in 5-h assays. MFC within sections of the atherosclerotic lesions from the ballooned rabbits as well as the MFC isolated from the same lesions in the presence of antioxidants, exhibited positive immunoreactivity with polyclonal guinea pig antisera and mouse monoclonal antibodies directed against malondialdehyde-LDL, and 4-hydroxynonal-LDL. The MFC also exhibited the capacity to induce the oxidation of LDL at rates comparable to those exhibited by MPM and rabbit aortic endothelial cells. These data provide direct evidence that arterial wall macrophages express modified LDL receptors in vivo, contain epitopes found in oxidized-LDL and are capable of oxidizing LDL even when maximally loaded with cholesterol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985115      PMCID: PMC294999          DOI: 10.1172/JCI115006

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits.

Authors:  M E Rosenfeld; W Palinski; S Ylä-Herttuala; S Butler; J L Witztum
Journal:  Arteriosclerosis       Date:  1990 May-Jun

2.  Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. I. Resolution of aortic cell populations by metrizamide density gradient centrifugation.

Authors:  N J Haley; H Shio; S Fowler
Journal:  Lab Invest       Date:  1977-09       Impact factor: 5.662

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

Authors:  S K Basu; J L Goldstein; G W Anderson; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

5.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.

Authors:  J L Goldstein; Y K Ho; S K Basu; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

6.  Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations.

Authors:  S Fowler; H Shio; N J Haley
Journal:  Lab Invest       Date:  1979-10       Impact factor: 5.662

7.  Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. III. Intracellular localization of cholesterol and cholesteryl ester.

Authors:  H Shio; N J Haley; S Fowler
Journal:  Lab Invest       Date:  1979-08       Impact factor: 5.662

8.  Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells.

Authors:  W Gamble; M Vaughan; H S Kruth; J Avigan
Journal:  J Lipid Res       Date:  1978-11       Impact factor: 5.922

9.  Macrophage foam cells from human aortic fatty streaks take up beta-VLDL and acetylated LDL in primary culture.

Authors:  O Jaakkola; S Ylä-Herttuala; T Särkioja; T Nikkari
Journal:  Atherosclerosis       Date:  1989-10       Impact factor: 5.162

10.  Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.

Authors:  H C Boyd; A M Gown; G Wolfbauer; A Chait
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

View more
  38 in total

1.  Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.

Authors:  W Palinski; S Hörkkö; E Miller; U P Steinbrecher; H C Powell; L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Development of a lipoprotein based molecular imaging MR contrast agent for the noninvasive detection of early atherosclerotic disease.

Authors:  L M Mitsumori; J L Ricks; M E Rosenfeld; U P Schmiedl; C Yuan
Journal:  Int J Cardiovasc Imaging       Date:  2004-12       Impact factor: 2.357

Review 3.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

4.  Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta.

Authors:  F Plane; K R Bruckdorfer; P Kerr; A Steuer; M Jacobs
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

5.  The effects of oxidized low density lipoproteins on inducible mouse macrophage gene expression are gene and stimulus dependent.

Authors:  T A Hamilton; J A Major; G M Chisolm
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

6.  Antioxidant activity of various teas against free radicals and LDL oxidation.

Authors:  Reiko Ohmori; Tamami Iwamoto; Motomi Tago; Tadakazu Takeo; Tomonori Unno; Hiroshige Itakura; Kazuo Kondo
Journal:  Lipids       Date:  2005-08       Impact factor: 1.880

7.  Immunological evidence for hypochlorite-modified proteins in human kidney.

Authors:  E Malle; C Woenckhaus; G Waeg; H Esterbauer; E F Gröne; H J Gröne
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

8.  Immunohistochemical study of intimal microvessels in coronary atherosclerosis.

Authors:  Y Zhang; W J Cliff; G I Schoefl; G Higgins
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

Review 9.  Oxidative modification of LDL: its pathological role in atherosclerosis.

Authors:  Hiroyuki Itabe
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

Review 10.  Why are low-density lipoproteins atherogenic?

Authors:  S G Young; S Parthasarathy
Journal:  West J Med       Date:  1994-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.